Intractable restless legs syndrome: role of prolonged-release oxycodone–naloxone

References

• TrenkwalderCPaulusWWaltersASThe restless legs syndromeLancet Neurol20054846547516033689
   PubMed Web of Science ®Google Scholar
• International Restless Legs Study Group2012 Revised IRLSSG diagnostic criteria for RLS2012 Available from: http://irlssg.org/diagnostic-criteriaAccessed January 27, 2016
   Google Scholar
• MontplaisirJBoucherSPoirierGLavigneGLapierreOLespérancePClinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteriaMov Disord199712161658990055
   PubMed Web of Science ®Google Scholar
• AllenRWaltersAMontplaisirJRestless legs syndrome prevalence and impact: REST general population studyArch Intern Med2005165111286129215956009
   PubMedGoogle Scholar
• Garcia-BorregueroDEgatzRWinkelmannJBergerKEpidemiology of restless legs syndrome: the current statusSleep Med Rev200610315316716762806
   PubMed Web of Science ®Google Scholar
• OhayonMMO’HaraRVitielloMVEpidemiology of restless legs syndrome: a synthesis of the literatureSleep Med Rev201216428329521795081
   PubMed Web of Science ®Google Scholar
• BassettiCMauerhoferDGuggerMMathisJHessCWRestless legs syndrome: a clinical study of 55 patientsEur Neurol2001452677411244268
   PubMed Web of Science ®Google Scholar
• EarleyCJConnorJRBeardJLMaleckiEAEpsteinDKAllenRPAbnormalities in CSF concentrations of ferritin and transferrin in restless legs syndromeNeurology20005481698170010762522
   PubMed Web of Science ®Google Scholar
• GigliGLAdoratiMDolsoPRestless legs syndrome in end-stage renal diseaseSleep Med20045330931515165541
   PubMed Web of Science ®Google Scholar
• MerlinoGFratticciLValenteMAssociation of restless legs syndrome in type 2 diabetes: a case-control studySleep200730786687117682657
   PubMed Web of Science ®Google Scholar
• ManconiMFerini-StrambiLFilippiMMulticenter case-control study on restless legs syndrome in multiple sclerosis: the REMS studySleep200831794495218655317
   PubMed Web of Science ®Google Scholar
• ManconiMGovoniVDe VitoARestless legs syndrome and pregnancyNeurology20046361065106915452299
   PubMed Web of Science ®Google Scholar
• O’KeeffeSTSecondary causes of restless legs syndrome in older peopleAge Ageing200534434935215886221
   PubMed Web of Science ®Google Scholar
• HeningWThe clinical neurophysiology of the restless legs syndrome and periodic limb movements. Part I: diagnosis, assessment, and characterizationClin Neurophysiol200411591965197415294199
   PubMed Web of Science ®Google Scholar
• TrenkwalderCPaulusWRestless legs syndrome: pathophysiology, clinical presentation and managementNat Rev Neurol20106633734620531433
   PubMed Web of Science ®Google Scholar
• ZintzarasEKitsiosGDPapathanasiouAARandomized trials of dopamine agonists in restless legs syndrome: a systematic review, quality assessment, and meta-analysisClin Ther201032222123720206780
   PubMed Web of Science ®Google Scholar
• García-BorregueroDAllenRPKohnenRDiagnostic standards for dopaminergic augmentation of restless legs syndrome: report from a World Association of Sleep Medicine-International Restless Legs Syndrome Study Group consensus conference at the Max Planck InstituteSleep Med20078552053017544323
   PubMed Web of Science ®Google Scholar
• Garcia-BorregueroDKohnenRSilberMHThe long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study GroupSleep Med201314767568423859128
   PubMed Web of Science ®Google Scholar
• Ferini-StrambiLMarelliSPharmacotherapy for restless legs syndromeExpert Opin Pharmacother20141581127123824745717
   PubMed Web of Science ®Google Scholar
• TrenkwalderCBenešHGroteLProlonged release oxycodone-naloxone for treatment of severe restless legs syndrome after failure of previous treatment: a double-blind, randomised, placebo-controlled trial with an open-label extensionLancet Neurol201312121141115024140442
   PubMed Web of Science ®Google Scholar
• HeningWAWaltersAKaveyNGidro-FrankSCoteLFahnSDyskinesias while awake and periodic movements in sleep in restless legs syndrome: treatment with opioidsNeurology19863610136313663762946
   PubMed Web of Science ®Google Scholar
• MundipharmaMundipharma receives positive European Commission decision on Targin^® (oxycodone/naloxone) for the treatment of restless legs syndrome [press release]2015 Available from: http://www.mundipharma.com/docs/default-source/press-releases-library/targin-rls-ec-positive.pdf?sfvrsn=0Accessed September 25, 2015
   Google Scholar
• Söderberg LöfdalKCAnderssonMLGustafssonLLCytochrome P450-mediated changes in oxycodone pharmacokinetics/pharmacodynamics and their clinical implicationsDrugs201373653354323605691
   PubMed Web of Science ®Google Scholar
• Mueller-LissnerSFixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipationAdv Ther201027958159020714946
   PubMed Web of Science ®Google Scholar
• LeppertWRole of oxycodone and oxycodone/naloxone in cancer pain managementPharmacol Rep201062457859120884999
   PubMed Web of Science ®Google Scholar
• KalsoEOxycodoneJ Pain Symptom Manage2005295 SupplS47S5615907646
   PubMed Web of Science ®Google Scholar
• MandemaJWKaikoRFOshlackBRederRFStanskiDRCharacterization and validation of a pharmacokinetic model for controlled-release oxycodoneBr J Clin Pharmacol19964267477568971431
   PubMed Web of Science ®Google Scholar
• LugoRAKernSEThe pharmacokinetics of oxycodoneJ Pain Palliat Care Pharmacother2004184173015760805
   PubMedGoogle Scholar
• ColuzziFMattiaCOxycodone: pharmacological profile and clinical data in chronic pain managementMinerva Anestesiol2005717–845146016012419
   PubMedGoogle Scholar
• SmithKHoppMMundinGSingle- and multiple-dose pharmacokinetic evaluation of oxycodone and naloxone in an opioid agonist/antagonist prolonged release combination in healthy adult volunteersClin Ther200830112051206819108793
   PubMed Web of Science ®Google Scholar
• MeissnerWLeyendeckerPMueller-LissnerSA randomised controlled trial with prolonged-release oral oxycodone and naloxone to prevent and reverse opioid-induced constipationEur J Pain2009131566418762438
   PubMed Web of Science ®Google Scholar
• NadstawekJLeyendeckerPHoppMPatient assessment of a novel therapeutic approach for the treatment of severe, chronic painInt J Clin Pract20086281159116718705820
   PubMed Web of Science ®Google Scholar
• DavisMPVargaJDickersonDWalshDLeGrandSBLagmanRNormal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversySupport Care Cancer2003112849212560936
   PubMed Web of Science ®Google Scholar
• Purdue PharmaProduct monograph: NTargin®: oxycodone hydrochloride/naloxone hydrochloride controlled release tablets2014 Available from: http://www.purdue.ca/files/2014-08-05_Targin-pm-mktg-eng.pdfAccessed September 25, 2015
   Google Scholar
• LöwensteinOLeyendeckerPHoppMCombined prolonged release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomized controlled trialExpert Opin Pharmacother200910453154319243306
   PubMed Web of Science ®Google Scholar
• LeowKPSmithMTThe antinociceptive potencies of oxycodone, noroxycodone and morphine after intracerebroventricular administration to ratsLife Sci19945417122912368164504
   PubMed Web of Science ®Google Scholar
• LalovicBKharaschEHofferCRislerLLiu-ChenLYShenDDPharmacokinetics and pharmacodynamics of oral oxycodone in healthy human subjects: role of circulating active metabolitesClin Pharmacol Ther200679546147916678548
   PubMed Web of Science ®Google Scholar
• SamerCFDaaliYWagnerMThe effects of CYP2D6 and CYP3A activities on the pharmacokinetics of immediate release oxycodoneBr J Pharmacol2010160490791820590587
   PubMed Web of Science ®Google Scholar
• SilverNAllenRPSenerthJEarleyCJA 10-year, longitudinal assessment of dopamine agonists and methadone in the treatment of restless legs syndromeSleep Med201112544044421239226
   PubMed Web of Science ®Google Scholar
• OndoWGMethadone for refractory restless legs syndromeMov Disord200520334534815580610
   PubMed Web of Science ®Google Scholar
• WaltersASWagnerMLHeningWASuccessful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placeboSleep19931643273328341893
   PubMed Web of Science ®Google Scholar
• LaurmaHMarkkulaJTreatment of restless legs syndrome with tramadol: an open studyJ Clin Psychiatry199960424124410221285
   PubMed Web of Science ®Google Scholar
• VetrugnoRLa MorgiaCD’AngeloRAugmentation of restless legs syndrome with long-term tramadol treatmentMov Disord200722342442717230457
   PubMed Web of Science ®Google Scholar
• EarleyCJAllenRPRestless legs syndrome augmentation associated with tramadolSleep Med20067759259316926116
   PubMed Web of Science ®Google Scholar
• LindvallPRuuthKJakobssonBNilssonSIntrathecal morphine as a treatment for refractory restless legs syndromeNeurosurgery2008636E120919057291
   PubMedGoogle Scholar
• JakobssonBRuuthKSuccessful treatment of restless legs syndrome with an implanted pump for intrathecal drug deliveryActa Anaesthesiol Scand200246111411711903084
   PubMed Web of Science ®Google Scholar
• RossDANarusMSNuttJGControl of medically refractory restless legs syndrome with intrathecal morphine: case reportNeurosurgery2008621E26318300885
   PubMedGoogle Scholar
• HornyakMKaubeHLong-term treatment of a patient with severe restless legs syndrome using intrathecal morphineNeurology201279242361236223197746
   PubMed Web of Science ®Google Scholar
• WaltersASOpioids and restless legs syndromeLancet Neurol201312121128112924140443
   PubMed Web of Science ®Google Scholar
• ScholzHTrenkwalderCKohnenRRiemannDKristonLHornyakMDopamine agonists for restless legs syndromeCochrane Database Syst Rev20113CD00600921412893
   PubMedGoogle Scholar
• HornyakMScholzHKohnenRBengelJKassubekJTrenkwalderCWhat treatment works best for restless legs syndrome? Meta-analyses of dopaminergic and non-dopaminergic medicationsSleep Med Rev201418215316423746768
   PubMed Web of Science ®Google Scholar
• FramptonJEOxycodone/naloxone PR: a review in severe refractory restless legs syndromeCNS Drugs201529651151826135898
   PubMed Web of Science ®Google Scholar
• PappagalloMIncidence, prevalence, and management of opioid bowel dysfunctionAm J Surg20011825A Suppl11S18S11755892
   PubMed Web of Science ®Google Scholar
• ColuzziFPappagalloMOpioid therapy for chronic noncancer pain: practice guidelines for initiation and maintenance of therapyMinerva Anestesiol2005717–842543316012415
   PubMedGoogle Scholar
• KurzASesslerDIOpioid-induced bowel dysfunction: pathophysiology and potential new therapiesDrugs200363764967112656645
   PubMed Web of Science ®Google Scholar
• LarkinPJSykesNPCentenoCThe management of constipation in palliative care: clinical practice recommendationsPalliat Med200822779680718838491
   PubMed Web of Science ®Google Scholar
• LeppertWThe place of oxycodone/naloxone in chronic pain managementContemp Oncol (Pozn)201317212813323788978
   PubMed Web of Science ®Google Scholar
• Sandner-KieslingALeyendeckerPHoppMLong-term efficacy and safety of combined prolonged-release oxycodone and naloxone in the management of non-cancer chronic painInt J Clin Pract201064676377420370845
   PubMed Web of Science ®Google Scholar
• SimpsonKLeyendeckerPHoppMFixed-ratio combination oxycodone/naloxone compared with oxycodone alone for the relief of opioid-induced constipation in moderate-to-severe noncancer painCurr Med Res Opin200824123503351219032132
   PubMed Web of Science ®Google Scholar
• VondrackovaDLeyendeckerPMeissnerWAnalgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic painJ Pain20089121144115418708300
   PubMed Web of Science ®Google Scholar
• AhmedzaiSHNauckFBar-SelaGBosseBLeyendeckerPHoppMA randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer painPalliat Med2012261506021937568
   PubMed Web of Science ®Google Scholar
• KuusniemiKZöllnerJSjövallSProlonged-release oxycodone/naloxone in postoperative pain management: from a randomized clinical trial to usual clinical practiceJ Int Med Res20124051775179323206459
   PubMed Web of Science ®Google Scholar
• García-BorregueroDWilliamsAMDopaminergic augmentation of restless legs syndromeSleep Med Rev201014533934620219397
   PubMed Web of Science ®Google Scholar
• MaestriMFuldaSFerini-StrambiLPolysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom diseaseSleep Med201415557057524767724
   PubMed Web of Science ®Google Scholar
• AllenRPChenCGarcia-BorregueroDComparison of pregabalin with pramipexole for restless legs syndromeN Engl J Med2014370762163124521108
   PubMed Web of Science ®Google Scholar